journal
MENU ▼
Read by QxMD icon Read
search

JACC. Heart Failure

journal
https://www.readbyqxmd.com/read/28624487/the-changing-landscape-of-atrial%C3%A2-fibrillation-time-to-target-heart-failure-prevention
#1
EDITORIAL
Darae Ko, Renate B Schnabel, Ludovic Trinquart, Emelia J Benjamin
No abstract text is available yet for this article.
June 14, 2017: JACC. Heart Failure
https://www.readbyqxmd.com/read/28624484/progression-to-stage-d-heart-failure-among-outpatients-with-stage-c-heart-failure-and-reduced-ejection-fraction
#2
Andreas P Kalogeropoulos, Ayman Samman-Tahhan, Jeffrey S Hedley, Andrew A McCue, Jonathan B Bjork, David W Markham, Kunal N Bhatt, Vasiliki V Georgiopoulou, Andrew L Smith, Javed Butler
OBJECTIVES: This study sought to estimate the rate of progression to Stage D heart failure (HF) among outpatients with Stage C HF and to identify risk factors for progression. BACKGROUND: The pool of patients who may be candidates for advanced HF therapies is growing. METHODS: We estimated 3-year progression to clinically determined Stage D HF and competing mortality among 964 outpatients with Stage C heart failure with reduced ejection fraction (HFrEF), where ejection fraction is ≤40%...
June 14, 2017: JACC. Heart Failure
https://www.readbyqxmd.com/read/28624485/time-to-take-the-failure-out%C3%A2-of%C3%A2-heart%C3%A2-failure-the-importance-of-optimism
#3
EDITORIAL
John G F Cleland, Pierpaolo Pellicori, Andrew L Clark, Mark C Petrie
No abstract text is available yet for this article.
June 1, 2017: JACC. Heart Failure
https://www.readbyqxmd.com/read/28624486/modifiable-risk-factors-for-incident-heart%C3%A2-failure-in-atrial-fibrillation
#4
Neal A Chatterjee, Claudia U Chae, Eunjung Kim, M Vinayaga Moorthy, David Conen, Roopinder K Sandhu, Nancy R Cook, I-Min Lee, Christine M Albert
OBJECTIVES: This study sought to identify modifiable risk factors and estimate the impact of risk factor modification on heart failure (HF) risk in women with new-onset atrial fibrillation (AF). BACKGROUND: Incident HF is the most common nonfatal event in patients with AF, although strategies for HF prevention are lacking. METHODS: We assessed 34,736 participants in the Women's Health Study who were free of prevalent cardiovascular disease at baseline...
May 31, 2017: JACC. Heart Failure
https://www.readbyqxmd.com/read/28624483/biomarker-profiles-of-acute%C3%A2-heart%C3%A2-failure%C3%A2-patients-with-a%C3%A2-mid-range-ejection%C3%A2-fraction
#5
Jasper Tromp, Mohsin A F Khan, Robert J Mentz, Christopher M O'Connor, Marco Metra, Howard C Dittrich, Piotr Ponikowski, John R Teerlink, Gad Cotter, Beth Davison, John G F Cleland, Michael M Givertz, Daniel M Bloomfield, Dirk J van Veldhuisen, Hans L Hillege, Adriaan A Voors, Peter van der Meer
OBJECTIVES: In this study, the authors used biomarker profiles to characterize differences between patients with acute heart failure with a midrange ejection fraction (HFmrEF) and compare them with patients with a reduced (heart failure with a reduced ejection fraction [HFrEF]) and preserved (heart failure with a preserved ejection fraction [HFpEF]) ejection fraction. BACKGROUND: Limited data are available on biomarker profiles in acute HFmrEF. METHODS: A panel of 37 biomarkers from different pathophysiological domains (e...
May 31, 2017: JACC. Heart Failure
https://www.readbyqxmd.com/read/28501521/associations-between-short-or-long-length%C3%A2-of-stay-and-30-day-readmission-and-mortality-in-hospitalized-patients-with-heart%C3%A2-failure
#6
Maneesh Sud, Bing Yu, Harindra C Wijeysundera, Peter C Austin, Dennis T Ko, Juarez Braga, Peter Cram, John A Spertus, Michael Domanski, Douglas S Lee
OBJECTIVES: This study sought to examine the associations between heart failure (HF)-related hospital length of stay and 30-day readmissions and HF hospital length of stay and mortality rates. BACKGROUND: Although reducing HF readmission and mortality rates are health care priorities, how HF-related hospital length of stay affects these outcomes is not fully known. METHODS: A population-level, multicenter cohort study of 58,230 patients with HF (age >65 years) was conducted in Ontario, Canada between April 1, 2003 and March 31, 2012...
May 10, 2017: JACC. Heart Failure
https://www.readbyqxmd.com/read/28501527/race-ethnic-differences-in-outcomes-among-hospitalized-medicare-patients-with-heart-failure-and-preserved-ejection%C3%A2-fraction
#7
Boback Ziaeian, Paul A Heidenreich, Haolin Xu, Adam D DeVore, Roland A Matsouaka, Adrian F Hernandez, Deepak L Bhatt, Clyde W Yancy, Gregg C Fonarow
OBJECTIVES: This study analyzed HFpEF patient characteristics and clinical outcomes according to race/ethnicity and adjusted for patient and hospital characteristics along with socioeconomic status (SES). BACKGROUND: The proportion of hospitalizations for heart failure with preserved ejection fraction (HFpEF) has increased over the last decade. Whether the short- and long-term outcomes differ between racial/ethnic groups is not well described. METHODS: The Get With The Guidelines-Heart Failure registry was linked to Medicare administrative data to identify hospitalized patients with HFpEF ≥65 years of age with left ventricular ejection fraction ≥50% between 2006 and 2014...
May 2, 2017: JACC. Heart Failure
https://www.readbyqxmd.com/read/28501526/do-we-need-another-walking-test
#8
EDITORIAL
Clinton A Brawner, Steven J Keteyian
No abstract text is available yet for this article.
May 2, 2017: JACC. Heart Failure
https://www.readbyqxmd.com/read/28501524/holding-the-readmission-gates-incentivizing-quality-and-cost-effective-care-for-heart-failure
#9
EDITORIAL
Gregg C Fonarow, Boback Ziaeian
No abstract text is available yet for this article.
May 2, 2017: JACC. Heart Failure
https://www.readbyqxmd.com/read/28501522/long-term-effects-of-flosequinan-on-the-morbidity-and-mortality-of-patients-with-severe-chronic-heart-failure-primary-results-of-the-profile-trial-after-24-years
#10
Milton Packer, Bertram Pitt, Jean-Lucien Rouleau, Karl Swedberg, David L DeMets, Lloyd Fisher
OBJECTIVES: The objective of this clinical trial was to evaluate the long-term effects of flosequinan on the morbidity and mortality of patients with severe chronic heart failure. BACKGROUND: Flosequinan was the first oral vasodilator to be used in the clinic to augment the effects of digitalis, diuretics, and angiotensin-converting enzyme inhibitors in heart failure. However, the drug activated neurohormonal systems and exerted both positive inotropic and chronotropic effects, raising concerns about its safety during long-term use...
May 2, 2017: JACC. Heart Failure
https://www.readbyqxmd.com/read/28501520/can-heart-failure-with-preserved-ejection%C3%A2-fraction-shed-light-on-the-mortality-readmissions-paradox
#11
EDITORIAL
Jennifer E Ho
No abstract text is available yet for this article.
May 2, 2017: JACC. Heart Failure
https://www.readbyqxmd.com/read/28396043/body-mass-index-and-cardiorespiratory-fitness-in-mid-life-and-risk-of-heart-failure%C3%A2-hospitalization-in-older-age-findings-from-the-cooper-center-longitudinal-study
#12
Ambarish Pandey, William K Cornwell, Benjamin Willis, Ian J Neeland, Ang Gao, David Leonard, Laura DeFina, Jarett D Berry
OBJECTIVES: This study evaluated the contributions of obesity and changes in body mass index (BMI) in mid-life to long-term heart failure (HF) risk independent of cardiorespiratory fitness (CRF) levels. BACKGROUND: Obesity and low CRF are well-established risk factors for HF. However, given the inverse association between CRF and obesity, the independent contributions of BMI toward HF risk are not fully understood. METHODS: We included 19,485 participants from the Cooper Center Longitudinal Study who survived to receive Medicare coverage, from 1999 to 2009...
March 30, 2017: JACC. Heart Failure
https://www.readbyqxmd.com/read/28396041/association-of-holter-derived-heart-rate-variability-parameters-with-the-development-of-congestive-heart-failure-in-the-cardiovascular-health-study
#13
Vaiibhav N Patel, Brian R Pierce, Rohan K Bodapati, David L Brown, Diane G Ives, Phyllis K Stein
OBJECTIVES: This study sought to determine whether Holter-based parameters of heart rate variability (HRV) are independently associated with incident heart failure among older adults in the CHS (Cardiovascular Health Study) as evidenced by an improvement in the predictive power of the Health Aging and Body Composition Heart Failure (Health ABC) score. BACKGROUND: Abnormal HRV, a marker of autonomic dysfunction, has been associated with multiple adverse cardiovascular outcomes but not the development of congestive heart failure (CHF)...
March 30, 2017: JACC. Heart Failure
https://www.readbyqxmd.com/read/28396040/risk-assessment-and-comparative-effectiveness-of-left-ventricular-assist-device-and-medical-management-in-ambulatory-heart-failure-patients-the-roadmap-study-2-year-results
#14
Randall C Starling, Jerry D Estep, Douglas A Horstmanshof, Carmelo A Milano, Josef Stehlik, Keyur B Shah, Brian A Bruckner, Sangjin Lee, James W Long, Craig H Selzman, Vigneshwar Kasirajan, Donald C Haas, Andrew J Boyle, Joyce Chuang, David J Farrar, Joseph G Rogers
OBJECTIVES: The authors sought to provide the pre-specified primary endpoint of the ROADMAP (Risk Assessment and Comparative Effectiveness of Left Ventricular Assist Device and Medical Management in Ambulatory Heart Failure Patients) trial at 2 years. BACKGROUND: The ROADMAP trial was a prospective nonrandomized observational study of 200 patients (97 with a left ventricular assist device [LVAD], 103 on optimal medical management [OMM]) that showed that survival with improved functional status at 1 year was better with LVADs compared with OMM in a patient population of ambulatory New York Heart Association functional class IIIb/IV patients...
March 30, 2017: JACC. Heart Failure
https://www.readbyqxmd.com/read/28396039/therapeutic-cardiorespiratory-fitness-to-prevent-and-treat-heart-failure
#15
EDITORIAL
Carl J Lavie, Steven J Keteyian, Hector O Ventura
No abstract text is available yet for this article.
March 30, 2017: JACC. Heart Failure
https://www.readbyqxmd.com/read/28571604/is-left-ventricular-ejection-fraction-by-echo-in-patients-with-atrial-fibrillation-reliable
#16
LETTER
Gang Huang, Junbo Xu, Tingjie Zhang
No abstract text is available yet for this article.
June 2017: JACC. Heart Failure
https://www.readbyqxmd.com/read/28571603/all-roads-lead-to-rome-myocardial-fibrosis
#17
LETTER
Levent Cerit
No abstract text is available yet for this article.
June 2017: JACC. Heart Failure
https://www.readbyqxmd.com/read/28571602/reply-decreased-mortality-with-beta-blockers-in-patients-with-heart-failure-and-coexisting-atrial-fibrillation
#18
LETTER
Julia Cadrin-Tourigny, Azadeh Shohoudi, Denis Roy, Paul Khairy
No abstract text is available yet for this article.
June 2017: JACC. Heart Failure
https://www.readbyqxmd.com/read/28571601/decreased-mortality-with-beta-blockers-in-patients-with-heart-failure-and-coexisting-atrial-fibrillation
#19
LETTER
Bart A Mulder, Dirk J Van Veldhuisen, Michiel Rienstra
No abstract text is available yet for this article.
June 2017: JACC. Heart Failure
https://www.readbyqxmd.com/read/28571600/development-of-acute%C3%A2-decompensated-heart%C3%A2-failure-therapies-is-the-journey-over
#20
EDITORIAL
Christopher M O'Connor
No abstract text is available yet for this article.
June 2017: JACC. Heart Failure
journal
journal
47572
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"